ADVANCED ALK/ROS1-POSITIVE NSCLC

Clinical trials for ADVANCED ALK/ROS1-POSITIVE NSCLC explained in plain language.

Never miss a new study

Get alerted when new ADVANCED ALK/ROS1-POSITIVE NSCLC trials appear

Sign up with your email to follow new studies for ADVANCED ALK/ROS1-POSITIVE NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Antidepressant may ease brain fog from lung cancer drug

Symptom relief Recruiting now

This study tests whether vortioxetine, an antidepressant known to boost thinking skills, can reduce the mental fogginess caused by the lung cancer drug lorlatinib. About 24 adults with advanced ALK-positive lung cancer who are already taking lorlatinib will receive vortioxetine. …

Matched conditions: ADVANCED ALK/ROS1-POSITIVE NSCLC

Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo • Aim: Symptom relief

Last updated Jun 27, 2026 13:05 UTC

ADVANCED ALK/ROS1-POSITIVE NSCLC

Get alerted when new ADVANCED ALK/ROS1-POSITIVE NSCLC trials appear

Antidepressant may ease brain fog from lung cancer drug